Galapagos NV
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 66 (Table of Contents)
Published: 5 Dec-2005
DOI: 10.3833/pdr.v2005.i66.591 ISSN: 1756-7874
Section: Company Profile
Fulltext:
Abstract
Galapagos formed as a 50:50 joint venture between Crucell and Tibotec focuses on genomics-based internal discovery program with service activities...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018